Insider · CIK 0002103581
Jared Kelly
Files at ONCY (ONCOLYTICS BIOTECH INC). First filing Feb 13, 2026, latest Mar 13, 2026.
Jared Kelly files SEC Form 4 as CEO and director at ONCY (ONCOLYTICS BIOTECH INC). Since Feb 13, 2026, Jared Kelly has reported 2 open-market buys worth $34k and 0 open-market sells worth $0, the latest filed on Mar 13, 2026.
A track record needs three past buys with six months of prices behind them; Jared Kelly has 0, so none is measured yet.
The newest scored trade: bought $4,848 of ONCY on Mar 12, 2026, filed Mar 13, 2026, scored 38 (weak). In the last 12 months: 2 buys worth $34k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ONCY: ONCOLYTICS BIOTECH INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | ONCOLYTICS BIOTECH INC | $4,848 5,050 shares | +5% | - | |
| 51Moderate | ONCOLYTICS BIOTECH INC | $30k 35,100 shares | +47% | - |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | ONCY ONCOLYTICS BIOTECH INC | AGrant or award Stock Optionderivative | +755,000 | $0.00 | $0 | 755,000 | Jun 3, 2026 |
| Mar 12, 2026 | ONCY ONCOLYTICS BIOTECH INC | POpen-market purchase Common Shares | +5,050 | $0.96 | $4,848 | 114,050 | Mar 13, 2026 |
| Feb 11, 2026 | ONCY ONCOLYTICS BIOTECH INC | POpen-market purchase Common Shares | +5,600 | $0.84 | $4,682 | 79,500 | Feb 13, 2026 |
| Feb 12, 2026 | ONCY ONCOLYTICS BIOTECH INC | POpen-market purchase Common Shares | +29,500 | $0.84 | $25k | 109,000 | Feb 13, 2026 |
Questions about Jared Kelly
Answered from the filings on this page, as of the latest one.
Is Jared Kelly buying or selling?
In the last 12 months Jared Kelly reported 2 open-market buys worth $34k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $4,848 of ONCY on Mar 12, 2026. Grants, option exercises and tax withholding are not counted.
How did Jared Kelly's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jared Kelly has 0.
Where does Jared Kelly file Form 4?
Jared Kelly has filed Form 4 at ONCY (ONCOLYTICS BIOTECH INC) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.